Method for enhanced parenteral nutrition
View Patent ↗A method for improved administration of nutrient is provide. The method includes co- or separate administration of a source of nutrients, especially carbohydrates, and insulinotropic peptides and derivatives, analogs, fragments and the like. The method provides high carbohydrate nutrition while avoiding hyper- and hypo-glycemia and their attendant deleterious effects.
1. A method for non-alimentary nutrition comprising administering by a parenteral route to a patient in need of parenteral nutrition;
a nutritively effective amount of nutrient composition comprising from about 2% to about 50% glucose or the equivalent thereof; and
an insulinotropic peptide or peptides selected from the groups consisting of a GLP-1, an exendin, the deletion sequences thereof, the natural and non-natural amino acid substitutes thereof, the C-terminus carboxyamides thereof, the C-terminus ketones thereof, the N-terminus modifications thereof, and any mixture thereof.
2. The method of claim 1 , wherein said insulinotropic peptide is an exendin.
3. The method of claim 1 , wherein said patient has not been diagnosed with diabetes mellitus.
4. The method of claim 1 , wherein said nutrient composition further comprises one or more amino acids, lipids, free fatty acids, mono-, di-, or tri-glycerides, glycerol, electrolytes, salts, minerals, vitamins or any combination thereof.
5. The method of claim 1 , wherein said insulinotropic peptide or peptides are administered by infusion at a rate of 0.01 to 50 pmol per kg of body weight of patient per minute.
6. The method of claim 1 , wherein said nutrient composition is in a first aqueous medium and said insulinotropic peptide is in a second aqueous medium or a pharmaceutically acceptable solid or gel tab or sustained release matrix.
7. The method of claim 1 , wherein said insulinotropic peptide or peptides are administered at a standardized concentration sufficient to provide a plateau level of the insulinotropic peptide or peptides in the patient's blood.
8. The method of claim 1 , wherein the said nutrient composition and said insulinotropic peptide or peptides are continuously administered.
9. The method of claim 1 , wherein said patient is non-diabetic.
10. The method of claim 1 , wherein said nutrient composition and said insulinotropic peptide or peptides are administered intravenously, together.
11. The method of claim 1 , wherein said nutrient composition and said insulinotropic peptide or peptides are administered intravenously, separately.
12. The method of claim 1 , wherein the administration of said nutrient composition produces a blood glucose level in the patient of from about 60 to 180 mg glucose per deciliter of blood, and the rate of administration is calculated to deliver up to about 1000 g of glucose or its equivalent per patient per day.
13. A method for non-alimentary nutrition comprising administering by a parenteral route to a patient in need of parenteral nutrition;
a nutrient composition to provide from about 600 g to about 1000 g of glucose or the equivalent thereof per 24 hours; and
an insulinotropic peptide or peptides selected from the group consisting of a GLP-1, an exendin, the deletion sequences thereof, the natural and non-natural amino acid substitutes thereof, the C-terminus carboxamides thereof, the C-terminus ketones thereof, the N-terminus modifications thereof, and any mixture thereof.
14. The method of claim 13 , wherein said insulinotrophic peptide is an exendin.
15. The method of claim 13 , wherein said nutrient composition further comprises one or more amino acids, lipids, free fatty acids, mono-, di-, or tri-glycerides, glycerol, electrolytes, salts, minerals, vitamins or any combination thereof.